Which of the following is a synthetic oxygen carrier?
Cataract in cases of diabetes mellitus is due to accumulation of ?
Bilirubin in serum can be measured by
In which condition is 5-Hydroxyindoleacetic acid (HIAA) elevated in urine?
What is the estimated blood glucose level in mg/dL for a patient with an HbA1c of 8% based on the conversion formula?
Which of the following is a positive acute phase protein that enhances the acute phase response?
Level of which of the following is not elevated in heart disease
Converging point of both pathways in coagulation is at:
Cystatin C levels are used for
Which of the following is not an acute phase reactant?
Explanation: **Perfluorocarbon** - **Perfluorocarbons** (PFCs) are synthetic organic compounds that are chemically inert and can dissolve large amounts of gases, including oxygen. - Due to their ability to carry oxygen, PFCs have been investigated as **blood substitutes** and in drug delivery systems. *2,4-dinitrophenol* - **2,4-dinitrophenol** (DNP) is an **uncoupler of oxidative phosphorylation**, meaning it prevents ATP synthesis while electron transport continues, generating heat instead. - It is a metabolic poison and has been used as a weight-loss drug but is not an oxygen carrier. *Chlorofluorocarbon* - **Chlorofluorocarbons** (CFCs) are organic compounds containing carbon, chlorine, and fluorine, primarily known for their role as **refrigerants** and in **aerosol propellants**. - CFCs are environmentally harmful due to their impact on the ozone layer and do not function as oxygen carriers. *1-fluoro-2,4-dinitrophenol* - **1-fluoro-2,4-dinitrophenol** is a derivative of dinitrophenol and would likely share similar properties as an **uncoupler of oxidative phosphorylation**. - It is not recognized for its ability to carry oxygen.
Explanation: ***Glycated crystallins*** - In diabetes, high glucose levels lead to **non-enzymatic glycation** of lens proteins, primarily **crystallins**. - Glycation causes aggregation and insolubilization of crystallins, leading to increased **light scattering** and cataract formation. - Additionally, the **polyol pathway** (glucose → sorbitol via aldose reductase) causes sorbitol accumulation in the lens, contributing to osmotic stress and protein damage. - Both glycation and sorbitol accumulation are key mechanisms in diabetic cataractogenesis. *Calcified crystallins* - While calcification can occur in some forms of cataracts (e.g., age-related, traumatic), it is **not the primary mechanism** for diabetic cataracts. - Diabetic cataracts are predominantly linked to **metabolic changes** (hyperglycemia-induced glycation and polyol pathway) rather than mineral deposition. *Glycated fibrillins* - **Fibrillin** is an extracellular matrix glycoprotein important for elastic fibers in connective tissues, but it is **not a major structural protein of the lens**. - The lens is composed primarily of **crystallins** (α, β, γ), not fibrillins. - Therefore, fibrillin glycation would not directly cause lens opacification. *Calcified fibrillins* - This option incorrectly identifies both the protein type and the mechanism. - **Fibrillin calcification** is not a known pathway for diabetic cataractogenesis. - Diabetic cataracts result from crystallin modifications, not fibrillin changes.
Explanation: ***Van den Bergh reaction*** - The **Van den Bergh reaction** is a common laboratory method used to quantify **bilirubin** in serum. - This method differentiates between direct (conjugated) and indirect (unconjugated) bilirubin using a **diazotized sulfanilic acid** reagent. *Ehrlich's Reaction* - **Ehrlich's reaction** is primarily used to detect **urobilinogen** in urine, not bilirubin in serum. - It involves the reaction of urobilinogen with **Ehrlich's reagent** (p-dimethylaminobenzaldehyde) to form a red color. *Schlesinger's Reaction* - **Schlesinger's reaction** is a test for the presence of **urobilin** in urine. - It uses a zinc salt, which reacts with urobilin to produce a characteristic **green fluorescence**. *Fouchet's Reaction* - **Fouchet's reagent** is used in urine analysis to detect the presence of **bilirubin** in a semi-quantitative manner, often indicating liver disease or biliary obstruction. - This reaction typically employs trichloroacetic acid and ferric chloride to produce a characteristic color change.
Explanation: ***Carcinoid*** - **Carcinoid tumors** can synthesize and release large amounts of **serotonin**, which is metabolized in the body to **5-HIAA**. - Elevated **urinary 5-HIAA** is a key diagnostic marker for **carcinoid syndrome**, indicating excessive serotonin production. *Alkaptonuria* - This is a rare genetic disorder characterized by the accumulation of **homogentisic acid** in the body, leading to dark urine upon standing and ultimately **ochronosis**. - It does not involve abnormalities in serotonin metabolism or 5-HIAA levels. *Albinism* - Albinism is a group of inherited disorders characterized by very **little or no melanin pigment production**, commonly affecting the skin, hair, and eyes. - This condition is related to **tyrosine metabolism** and has no direct link to 5-HIAA levels. *Phenylketonuria* - **PKU** is a metabolic disorder caused by a deficiency in the enzyme **phenylalanine hydroxylase**, leading to a buildup of **phenylalanine** in the body. - This condition primarily affects phenylalanine metabolism and has no direct relationship with 5-HIAA levels, which are associated with serotonin metabolism.
Explanation: ***200*** - The estimated average glucose (eAG) can be calculated from HbA1c using the formula: **eAG (mg/dL) = 28.7 × HbA1c (%) – 46.7**. - For an HbA1c of 8%, the calculation is: **28.7 × 8 – 46.7 = 229.6 – 46.7 = 182.9 mg/dL**, which is closest to 200 mg/dL among the given options. *120* - An eAG of 120-125 mg/dL would correspond to an **HbA1c between 5.8% and 6.0%**, which is below the given 8%. - This value typically reflects **well-controlled or pre-diabetic** blood glucose levels. *160* - An eAG of 160 mg/dL would correspond to an **HbA1c of approximately 7.0-7.2%**, which is lower than the given 8%. - This level is often the target for HbA1c in many **diabetic management guidelines**, but not for 8%. *240* - An eAG of 240 mg/dL would correspond to an **HbA1c of approximately 9.9%**, which is significantly higher than the given 8%. - This indicates **poorly controlled diabetes** and a much higher average blood glucose level.
Explanation: ***Fibrinogen*** - **Fibrinogen** is a key **positive acute phase protein** whose concentration increases significantly during inflammation - Its elevation contributes to the acute phase response by promoting **blood clotting** and influencing **erythrocyte sedimentation rate (ESR)** - Along with C-reactive protein (CRP), haptoglobin, and serum amyloid A, fibrinogen is among the major positive acute phase reactants *Transferrin* - **Transferrin** is a **negative acute phase protein**, meaning its concentration decreases during inflammation - This reduction is part of the body's iron-sequestration strategy to limit iron availability for invading pathogens - The decrease in transferrin helps restrict bacterial growth by reducing available iron *Albumin* - **Albumin** is a prominent **negative acute phase protein**, with its concentration decreasing during acute inflammation due to redistribution and reduced synthesis - It plays a vital role in maintaining **oncotic pressure** and transporting various substances - Its decline reflects the severity of inflammation and is used as a marker of the acute phase response *Prealbumin* - **Prealbumin** (also known as transthyretin) is a **negative acute phase protein** and a sensitive marker of nutritional status - Its rapid decline during inflammation makes it a useful indicator, as its synthesis is quickly reduced - It has a short half-life (2-3 days), making it more sensitive to acute changes than albumin
Explanation: ***5-nucleotidase*** - While other enzymes like LDH, SGOT, and ALP can be elevated in various conditions including heart disease (especially in the context of tissue damage), 5-nucleotidase is **not typically elevated in heart disease**. - Its elevation is more commonly associated with **biliary obstruction** or certain liver pathologies. *LDH* - **Lactate dehydrogenase (LDH)** is a marker of **cellular damage** and can be elevated in myocardial infarction, though it is less specific than troponins. - LDH levels rise later than CK-MB and remain elevated longer, indicating persistent tissue injury. *SGOT* - **Serum glutamic oxaloacetic transaminase (SGOT)**, also known as **aspartate aminotransferase (AST)**, is elevated in acute **myocardial infarction** due to cardiac muscle damage. - While it's a marker for cardiac injury, it's not specific as it's also highly concentrated in the liver. *ALP* - **Alkaline phosphatase (ALP)** can be mildly elevated in heart failure due to **hepatic congestion** caused by reduced cardiac output. - While its primary diagnostic significance is in bone and liver disease, its elevation in advanced heart disease is usually a secondary consequence.
Explanation: ***Stuart factor X*** [1][2] - It is the main **converging point** of the coagulation cascade, where both the intrinsic and extrinsic pathways meet to initiate the common pathway [1]. - Activated factor X leads to the conversion of **prothrombin to thrombin**, pivotal for clot formation [2]. *Factor VII* [2] - Primarily involved in the **extrinsic pathway** of coagulation, activating factor X, but does not serve as a converging point. - Its function is limited to starting the coagulation cascade, particularly upon tissue injury. *Factor IX* [2] - A key component of the **intrinsic pathway**, it leads to the activation of factor X but is not the point where both pathways converge. - It requires **factor VIII** for its activation, further illustrating its role within a specific pathway. *Factor VIII* - Also part of the **intrinsic pathway**, it acts as a cofactor for factor IX but does not integrate both pathways into a common point. - Its deficiency is associated with **Hemophilia A**, underscoring its specific pathway involvement. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 128-130. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 582-583.
Explanation: ***Estimating GFR*** - **Cystatin C** is a **proteinase inhibitor** produced by all nucleated cells at a constant rate, and its level in the blood is inversely related to the **glomerular filtration rate (GFR)**. - Unlike **creatinine**, Cystatin C levels are less affected by **muscle mass, diet, or inflammation**, making it a more reliable marker for early and subtle changes in GFR, especially in certain populations. *Detecting UTI* - **Urinary tract infections (UTIs)** are primarily detected through **urinalysis** (presence of **leukocytes, nitrites**, and **bacteria**) and **urine culture**. - **Cystatin C** is a serum marker for renal function and has no direct role in detecting the presence of bacterial infection in the urinary tract. *Estimating difference between CRF and ARF* - Differentiating between **chronic renal failure (CRF)** and **acute renal failure (ARF)** typically involves assessing the **chronicity of symptoms**, trend in **creatinine levels**, and **kidney size** and **echogenicity** on ultrasound. - While Cystatin C can reflect current GFR, it doesn't inherently provide discriminatory power between acute and chronic processes without serial measurements or additional clinical context. *Screening for Renal Ca* - **Renal cell carcinoma (RCC)** screening is primarily done using **imaging techniques** like **ultrasonography, CT, or MRI**, especially in individuals with risk factors or symptoms like **hematuria**. - **Cystatin C** is a marker of kidney function and does not serve as a tumor marker for renal cancer.
Explanation: ***Endothelin*** - Endothelin is a **vasoconstrictive peptide** primarily involved in regulating **blood vessel tone** and blood pressure. - While it plays a role in processes like inflammation and tissue repair, it is not synthesized or regulated in the same rapid, systemic manner as a classic acute phase reactant. *C-reactive protein* - **C-reactive protein (CRP)** is a rapidly responding acute phase reactant produced by the liver in response to **inflammation**, infection, and tissue injury. - Its levels can rise dramatically within hours of an inflammatory stimulus and are used as a marker for disease activity. *Haptoglobin* - **Haptoglobin** is an acute phase reactant that binds to free **hemoglobin** released from red blood cells during hemolysis, preventing oxidative damage. - Its levels typically increase during acute inflammation or infection, although it can also decrease with severe hemolysis. *Fibrinogen* - **Fibrinogen** is a critical acute phase protein involved in the **coagulation cascade** and wound healing. - Its concentration increases significantly during acute inflammation, contributing to the elevated **erythrocyte sedimentation rate (ESR)**.
Liver Function Tests
Practice Questions
Kidney Function Tests
Practice Questions
Cardiac Markers and Enzymes
Practice Questions
Pancreatic Function Tests
Practice Questions
Glucose Tolerance Tests
Practice Questions
Lipid Profile and Cardiovascular Risk
Practice Questions
Tumor Markers
Practice Questions
Hormonal Assays and Interpretation
Practice Questions
Electrolytes and Acid-Base Balance Tests
Practice Questions
Cerebrospinal Fluid Analysis
Practice Questions
Point-of-Care Testing
Practice Questions
Quality Control in Clinical Biochemistry
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free